Burgeoning blockchain pilots to prove value in clinical trials
Blockchain technology is becoming more relevant in the face of increasing patient-generated data and data ownership.
By
Disruptive Start-ups To Watch Out for
Latest in
Disruptive Start-ups To Watch Out for
GW Pharmaceuticals and pain continue to dominate cannabinoid clinical trials
GW Pharmaceuticals continues to be top industry sponsor for cannabinoid clinical trials, while pain remains the top indication.
By
Revealed: drug development companies best positioned to weather future industry disruption
Our analysis reveals that companies from USA are some of the best-prepared players in the drug development game.
By
Plaque psoriasis and psoriatic arthritis: trials to watch in 2022
Four Phase II and III trials in plaque psoriasis or psoriatic arthritis have results expected in 2H 2022, and five…
By
Internet of Things: a tsunami of clinical trial data
IoT devices allow sponsors to access an unprecedented volume and variety of data, but are they equipped to ride the…
By
Phase 0 clinical trials: what you need to know
Clinical Trials Arena breaks down the two most common types of Phase 0 trials, including window of opportunity trials in…
By
Arrowhead doses subjects in two Phase I/IIa pulmonary disease trials
Both trials will analyse the safety and tolerability, pharmacokinetics and pharmacodynamics of the two RNAi therapeutics.
Parkinson’s disease: major drug trial results to watch in 2022
Four clinical trials in Parkinson’s disease with readouts the second half of 2022 target motor symptom fluctuations and cognitive impairment.
By